339 related articles for article (PubMed ID: 20631416)
1. Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.
Botting RM
Pharmacol Rep; 2010; 62(3):518-25. PubMed ID: 20631416
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting RM
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():113-24. PubMed ID: 17218763
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of aspirin.
Vane JR; Botting RM
Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
[TBL] [Abstract][Full Text] [Related]
4. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice.
Ayoub SS; Colville-Nash PR; Willoughby DA; Botting RM
Eur J Pharmacol; 2006 May; 538(1-3):57-65. PubMed ID: 16674937
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-kappaB and other unidentified targets.
Terracciano S; Aquino M; Rodriquez M; Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
Curr Med Chem; 2006; 13(16):1947-69. PubMed ID: 16842204
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of aspirin-like drugs.
Vane JR; Botting RM
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
[TBL] [Abstract][Full Text] [Related]
7. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; KwiecieĊ S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
Cronstein BN
Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
[TBL] [Abstract][Full Text] [Related]
9. Closing in on a stomach-sparing aspirin substitute.
Service RF
Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
[No Abstract] [Full Text] [Related]
10. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
Giuliano F; Warner TD
Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
[TBL] [Abstract][Full Text] [Related]
11. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
12. Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.
Swierkosz TA; Jordan L; McBride M; McGough K; Devlin J; Botting RM
Med Sci Monit; 2002 Dec; 8(12):BR496-503. PubMed ID: 12503027
[TBL] [Abstract][Full Text] [Related]
13. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective.
Brune K; Neubert A
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S51-7. PubMed ID: 11695253
[TBL] [Abstract][Full Text] [Related]
15. The development of COX2 inhibitors.
Flower RJ
Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis.
Bunimov N; Laneuville O
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):268-77. PubMed ID: 19075637
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology of cyclooxygenase 2 inhibition].
Beubler E
Wien Med Wochenschr; 2003; 153(5-6):95-9. PubMed ID: 12705061
[TBL] [Abstract][Full Text] [Related]
18. Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs.
Smith WL; Meade EA; Dewitt DL
Adv Exp Med Biol; 1997; 400A():189-96. PubMed ID: 9547557
[No Abstract] [Full Text] [Related]
19. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
Celotti F; Durand T
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
Botting RM
Clin Infect Dis; 2000 Oct; 31 Suppl 5():S202-10. PubMed ID: 11113024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
